- Home
- FLYX vs AMRN Comparison
FLYX vs AMRN Comparison
Compare FLYX & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLYX
- AMRN
- Stock Information
- Founded
- FLYX 2015
- AMRN 1989
- Country
- FLYX United States
- AMRN Ireland
- Employees
- FLYX N/A
- AMRN N/A
- Industry
- FLYX Blank Checks
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- FLYX Finance
- AMRN Health Care
- Exchange
- FLYX Nasdaq
- AMRN Nasdaq
- Market Cap
- FLYX 175.8M
- AMRN 189.2M
- IPO Year
- FLYX N/A
- AMRN 1993
- Fundamental
- Price
- FLYX $2.96
- AMRN $0.45
- Analyst Decision
- FLYX Hold
- AMRN Buy
- Analyst Count
- FLYX 1
- AMRN 1
- Target Price
- FLYX N/A
- AMRN N/A
- AVG Volume (30 Days)
- FLYX 18.5K
- AMRN 1.7M
- Earning Date
- FLYX 01-01-0001
- AMRN 10-30-2024
- Dividend Yield
- FLYX N/A
- AMRN N/A
- EPS Growth
- FLYX N/A
- AMRN N/A
- EPS
- FLYX N/A
- AMRN N/A
- Revenue
- FLYX $311,873,000.00
- AMRN $241,021,000.00
- Revenue This Year
- FLYX $15.91
- AMRN N/A
- Revenue Next Year
- FLYX $39.64
- AMRN N/A
- P/E Ratio
- FLYX N/A
- AMRN N/A
- Revenue Growth
- FLYX N/A
- AMRN N/A
- 52 Week Low
- FLYX $1.79
- AMRN $0.43
- 52 Week High
- FLYX $24.21
- AMRN $1.37
- Technical
- Relative Strength Index (RSI)
- FLYX 70.23
- AMRN 40.10
- Support Level
- FLYX $2.20
- AMRN $0.43
- Resistance Level
- FLYX $2.67
- AMRN $0.49
- Average True Range (ATR)
- FLYX 0.31
- AMRN 0.03
- MACD
- FLYX 0.06
- AMRN 0.00
- Stochastic Oscillator
- FLYX 73.60
- AMRN 18.70
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 90 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.